Supply shortage of Fasturtec (rasburicase) 7.5 mg/5 ml powder and solvent for concentrate for solution for infusion (EU/1/00/170/002)
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Fasturtec
|
| Active substance |
rasburicase
|
| Therapeutic area (MeSH) |
Hyperuricemia
|
| Procedure number |
EMEA/H/C/000331
|
| DHPC type |
Medicine shortage
|
| Human ATC code |
V03AF07
|
| Dissemination date |
17/02/2023
|